Investigation of adverse events following immunization with liquid pentavalent vaccine in Sri Lanka
For further information
Vaccine safety: Dr Patrick Zuber (zuberp@who.int) and Dr Adwoa Bentsi-Enchill (bentsienchilla@who.int)
Vaccine quality and prequalification: Ms Carmen Rodriguez Hernandez (rodriguezhernandezc@who.int)
Communication: Mrs Alison Brunier (bruniera@who.int)